Call Center Representative (2nd Shift - Mon-Fri 11:30am-8:00pm) - Richmond, Virginia jobs in United States
cer-icon
Apply on Employer Site
company-logo

Celerion · 2 months ago

Call Center Representative (2nd Shift - Mon-Fri 11:30am-8:00pm) - Richmond, Virginia

Celerion is committed to swift, exceptional clinical research through translational medicine. They are currently seeking a Call Center Representative to join their Richmond, Virginia team, responsible for answering inbound calls and making outbound calls regarding tobacco study participation, as well as collecting and entering participant information into their database system.

Health CarePharmaceutical

Responsibilities

Answer inbound calls and make outbound calls to/from the public interested in information regarding tobacco study participation
Collect and enter participant information into our computer database system
Promote additional study participation and referrals from current study participants
Make reminder call-outs to study participants that are registered for screenings

Qualification

Customer serviceData entryCall center experienceSales experienceCommunication skills

Required

High School diploma or equivalent required
Must demonstrate excellent communication skills
Must demonstrate commitment to providing outstanding customer service
Able to sort information and interpret written and verbal instructions
Accuracy and attention to detail
Ability to work in required work environment, including but not limited to exposure to second hand smoke from combustible cigarettes and vapors from electronic cigarettes on a daily basis
According to the Code of Virginia 18.2-371.2B, employees must be 21 years of age to work around tobacco products

Preferred

Previous Call Center experience preferred
Data entry experience preferred
One year sales, telemarketing, promotional, public relations or related experience preferred

Company

Celerion

company-logo
Celerion, a leader in early clinical research, delivers Applied Translational Medicine.

Funding

Current Stage
Late Stage
Total Funding
unknown
2022-11-03Acquired

Leadership Team

leader-logo
Susan C. Thornton
President and CEO
linkedin
leader-logo
JoAnne Rosal
Chief Financial Officer
linkedin
Company data provided by crunchbase